TradingKey

Más Datos de Hologic Inc Compañía

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Información de la empresa

Símbolo de cotizaciónHOLX

Nombre de la empresaHologic Inc

Fecha de salida a bolsaMar 01, 1990

Fundada en1990

Director ejecutivoMr. Stephen P. (Steve) Macmillan

Número de empleados7063

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 01

Dirección250 Campus Drive

CiudadMARLBOROUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01752

Teléfono15082632900

Sitio Webhttps://www.hologic.com/

Símbolo de cotizaciónHOLX

Fecha de salida a bolsaMar 01, 1990

Fundada en1990

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

7.06K

+15.71%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

6.09K

-1.12%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Ms. Stacey D. Stewart

Independent Director

3.60K

+107.62%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

+7.02%

Ms. Christiana Stamoulis

Independent Director

47.34K

+4.10%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

--

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

636.90M

63.35%

Service

207.90M

20.68%

Capital equipment, components and software

155.80M

15.50%

Other

4.70M

0.47%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

744.90M

74.10%

Europe

146.50M

14.57%

Asia

59.70M

5.94%

Rest of World

54.20M

5.39%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

636.90M

63.35%

Service

207.90M

20.68%

Capital equipment, components and software

155.80M

15.50%

Other

4.70M

0.47%

Estadísticas de accionistas

Actualizado: vie., 16 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.99%

T. Rowe Price Investment Management, Inc.

10.81%

BlackRock Institutional Trust Company, N.A.

6.04%

State Street Global Advisors (US)

4.54%

Morgan Stanley Investment Management Ltd. (UK)

3.68%

Other

62.94%

Accionistas

Proporción

The Vanguard Group, Inc.

11.99%

T. Rowe Price Investment Management, Inc.

10.81%

BlackRock Institutional Trust Company, N.A.

6.04%

State Street Global Advisors (US)

4.54%

Morgan Stanley Investment Management Ltd. (UK)

3.68%

Other

62.94%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

65.52%

Investment Advisor/Hedge Fund

28.32%

Hedge Fund

3.30%

Pension Fund

2.75%

Research Firm

2.56%

Bank and Trust

1.78%

Sovereign Wealth Fund

0.90%

Individual Investor

0.86%

Family Office

0.05%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

1591

236.03M

105.92%

-8.05M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

2023Q1

1582

247.98M

100.57%

-12.56M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

26.72M

11.99%

-76.11K

-0.28%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

17.69M

7.94%

-250.35K

-1.40%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

13.46M

6.04%

-188.75K

-1.38%

Mar 31, 2025

State Street Global Advisors (US)

10.11M

4.54%

-235.58K

-2.28%

Mar 31, 2025

Morgan Stanley Investment Management Ltd. (UK)

8.21M

3.68%

-232.77K

-2.76%

Mar 31, 2025

Victory Capital Management Inc.

6.61M

2.97%

+1.69M

+34.41%

Mar 31, 2025

Geode Capital Management, L.L.C.

5.73M

2.57%

-948.00

-0.02%

Mar 31, 2025

Mitsubishi UFJ Asset Management Co., Ltd.

4.47M

2.01%

+69.88K

+1.59%

Mar 31, 2025

Invesco Capital Management LLC

4.37M

1.96%

+716.65K

+19.63%

Mar 31, 2025

Columbia Threadneedle Investments (US)

3.40M

1.53%

+19.27K

+0.57%

Mar 31, 2025

ETFs relacionados

Actualizado: hace 13 horas

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

4%

John Hancock Fundamental All Cap Core ETF

3.42%

LeaderShares AlphaFactor Tactical Focused ETF

3.32%

First Trust Indxx Medical Devices ETF

2.07%

Formidable ETF

1.96%

First Trust Health Care Alphadex Fund

1.87%

SPDR S&P Health Care Equipment ETF

1.84%

Brandes US Small-Mid Cap Value ETF

1.79%

Invesco S&P 500 Equal Weight Health Care ETF

1.67%

iShares U.S. Medical Devices ETF

1.65%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción4%

John Hancock Fundamental All Cap Core ETF

Proporción3.42%

LeaderShares AlphaFactor Tactical Focused ETF

Proporción3.32%

First Trust Indxx Medical Devices ETF

Proporción2.07%

Formidable ETF

Proporción1.96%

First Trust Health Care Alphadex Fund

Proporción1.87%

SPDR S&P Health Care Equipment ETF

Proporción1.84%

Brandes US Small-Mid Cap Value ETF

Proporción1.79%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.67%

iShares U.S. Medical Devices ETF

Proporción1.65%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Hologic Inc

67.160USD

Hologic Inc

67.160

Descripción general

Compañía

Finanzas